Advanced lipid testing holds significant potential in cardiovascular care by enhancing risk prediction beyond standard lipid panels. For patients, this means more tailored treatment and better outcomes by addressing residual risk not captured by traditional LDL-C assessments​. 

In this interview, Drs. Laxmi Mehta and Michael Shapiro discuss the role and importance of advanced lipid testing.

Related References:

1. Soffer DE, Marston NA, Maki KS, et al. Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: an expert clinical consensus from the National Lipid Association. J Clin Lipidol 2024;18:e647-e-663. 
2. Tsimikas S. A test in context: lipoprotein(a): diagnosis, prognosis, controversies, and emerging therapies. J Am Coll Cardiol 2017;69:692-711